Mostrar el registro sencillo del ítem

dc.contributor.authorRayatpour, Atefeh
dc.contributor.authorFarhangi, Sahar
dc.contributor.authorVerdaguer, Ester
dc.contributor.authorOlloquequi, Jordi
dc.contributor.authorUreña, Jesús Mariano
dc.contributor.authorAuladell, Carme
dc.contributor.authorJavan, Mohammad
dc.date.accessioned2021-11-09T16:03:06Z
dc.date.available2021-11-09T16:03:06Z
dc.date.issued2021-10
dc.identifier10.3390/ph14101031
dc.identifier.issn14248247
dc.identifier.urihttps://hdl.handle.net/20.500.12728/9682
dc.description.abstractDespite the significant differences in pathological background of neurodegenerative diseases, epileptic seizures are a comorbidity in many disorders such as Huntington disease (HD), Alzheimer’s disease (AD), and multiple sclerosis (MS). Regarding the last one, specifically, it has been shown that the risk of developing epilepsy is three to six times higher in patients with MS compared to the general population. In this context, understanding the pathological processes underlying this connection will allow for the targeting of the common and shared pathological pathways involved in both conditions, which may provide a new avenue in the management of neurological disorders. This review provides an outlook of what is known so far about the bidirectional association between epilepsy and MS.es_ES
dc.language.isoenes_ES
dc.publisherMDPIes_ES
dc.subjectDemyelinationes_ES
dc.subjectEpilepsyes_ES
dc.subjectMultiple sclerosises_ES
dc.subjectNeurodegenerationes_ES
dc.subjectSeizurees_ES
dc.titleThe cross talk between underlying mechanisms of multiple sclerosis and epilepsy may provide new insights for more efficient therapieses_ES
dc.typeArticlees_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem